surpass aneurysm-embolization system
surpass medical ltd. - רופא - the aneurysm-embolization system is indicated for use for the treatment of saccular, or fusiform intracranial aneurysms arising from a parent vessel with a diameter of ?2 mm and ?6 mm.
ultrasound doppler ,plethysmograph,vascular diagnostic devices systems
מדלייף בע"מ-ציוד רפואי ופתרונות מתקדמים - רופא - מערכות דופלר כלי דם נישאות,מערכות לבדיקה טיסידי,מעבדה למיפוי כלי דם,מערכות פיפיגי-ראה מודלים
סוליריס
alexion pharma israel ltd - eculizumab - תרכיז להכנת תמיסה לאינפוזיה - eculizumab 10 mg/ml - eculizumab - eculizumab - soliris is indicated for the treatment of patients with: - paroxysmal nocturnal hemoglobinuria ( pnh ).- atypical hemolytic uremic syndrome (ahus).
ואביסמו
roche pharmaceuticals (israel) ltd - faricimab - תמיסה להזרקה - faricimab 120 mg/ml - faricimab
נקסבר
bayer israel ltd - sorafenib as tosylate - טבליות מצופות פילם - sorafenib as tosylate 200 mg - sorafenib - sorafenib - nexavar is indicated for the treatment of patients with advanced renal cell carcinoma. treatment of patients with hepatocellular carcinoma.
נקסבר
bayer israel ltd - sorafenib as tosylate - טבליות מצופות פילם - sorafenib as tosylate 200 mg - sorafenib - sorafenib - nexavar is indicated for the treatment of patients with advanced renal cell carcinoma. treatment of patients with hepatocellular carcinoma.
פרופקס 300 מג
taro pharmaceutical industries ltd - propafenone hydrochloride - טבליה - propafenone hydrochloride 300 mg - propafenone - propafenone - prophylaxis and treatment of ventricular arrhythmias. prophylaxis and treatment of atrial fibrillation and flutter. prophylaxis and treatment of paroxysmal supraventricular tachycardia (psvt) associated with disabling symptoms.
פרופקס 150 מג
taro pharmaceutical industries ltd - propafenone hydrochloride - טבליה - propafenone hydrochloride 150 mg - propafenone - propafenone - prophylaxis and treatment of ventricular arrhythmias. prophylaxis and treatment of atrial fibrillation and flutter. prophylaxis and treatment of paroxysmal supraventricular tachycardia (psvt) associated with disabling symptoms.